The Great Debate: What is Enough … Women in Clinical Trials (debate portion only)

05 Jun 2018 01:01:21 0
366
0 0

This is the debate portion of the program "The Great Debate: What is Enough ... Women in Clinical Trials?". Recorded on May 16th, 2018, and sponsored by the FDA Office of Women’s Health. See the Keynote remarks for The Great Debate at: https://youtu.be/zBMMOOTgHdg

The Great Debate centered on the challenges and complexity of the question “What is enough?” when determining participation of women in cardiovascular disease clinical trials. The debate participants were two leading cardiovascular experts: Ellis F. Unger, M.D., FDA Center for Drug Evaluation and Research, and Rita Redberg, M.D., M.Sc., F.A.C.C., UCSF. It was a robust discussion centering on a complex question that has been debated among academia, federal, and non-government and consumer organizations for more than a quarter century.

Related of "The Great Debate: What is Enough … Women in Clinical Trials (debate portion only)" Videos